Comparison of Complement Activity in Adult and Preterm Sheep Serum

American Journal of Reproductive Immunology

Volumn 73, Issue 3, 2015, Pages 232-241

  Ahmed, Shatha ^a,b   Kemp, Matthew W ^c   Payne, Matthew S ^c   Kallapur, Suhas G ^c,d   Stock, Sarah J ^e   Marsh, Henry C ^f   Jobe, Alan H ^c,d   Newnham, John P ^c   Spiller, Owen B ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF MOSUL   (Iraq)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d UNIVERSITY OF CINCINNATI   (United States)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f Celldex Therapeutics Inc   (United Kingdom)

Author keywords

Antibody; Complement; Functional assay; Preterm neonate; Sheep

Indexed keywords

COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT INHIBITOR; ERYTHROCYTE ANTIBODY; IMMUNOGLOBULIN G; COMPLEMENT; COMPLEMENT RECEPTOR; HETEROPHILE ANTIBODY; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIGEN BINDING; ARTICLE; COMPARATIVE STUDY; COMPLEMENT ACTIVATION; COMPLEMENT BLOOD LEVEL; CONTROLLED STUDY; CROSS REACTION; ERYTHROCYTE; FEMALE; GUINEA PIG; HEMOLYSIS; HUMAN; HUMAN TISSUE; IMMUNE FUNCTION TEST; MATERNAL SERUM; NEWBORN; NONHUMAN; PASSIVE IMMUNIZATION; PATHOGENESIS; PLACENTAL TRANSFER; PREMATURITY; PRIORITY JOURNAL; RABBIT; RAT; SENSITIZATION; SHEEP; SHEEP ERYTHROCYTE; TARGET CELL; AGE; ANIMAL; BLOOD; CHICKEN; FETUS; FETUS BLOOD; IMMUNOLOGY; PREGNANCY; SPECIES DIFFERENCE;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, HETEROPHILE; CHICKENS; COMPLEMENT SYSTEM PROTEINS; CROSS REACTIONS; ERYTHROCYTES; FEMALE; FETAL BLOOD; FETUS; GUINEA PIGS; HEMOLYSIS; HUMANS; PEPTIDE FRAGMENTS; PREGNANCY; RABBITS; RATS; RECEPTORS, COMPLEMENT; RECOMBINANT PROTEINS; SHEEP; SPECIES SPECIFICITY;

EID: 84922801019     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12299     Document Type: Article

References (39)

1. McGreal EP, Hearne K, Spiller OB: Off to a slow start: under-development of the complement system in term newborns is more substantial following premature birth. Immunobiology 2012; 217:176-186.
2. Hansen S, Selman L, Palaniyar N, Ziegler K, Brandt J, Kliem A, Jonasson M, Skjoedt MO, Nielsen O, Hartshorn K, Jørgensen TJ, Skjødt K, Holmskov U: Collectin 11 (CL-11, CL-K1) is a MASP-1/3-associated plasma collectin with microbial-binding activity. J Immunol 2010; 185:6096-6104.
3. Degn SE, Thiel S: Humoral pattern recognition and the complement system. Scand J Immunol 2013; 78:181-193.
4. Haas KM, Toapanta FR, Oliver JA, Poe JC, Weis JH, Karp DR, Bower JF, Ross TM, Tedder TF, J Cutting edge: C3d functions as a molecular adjuvant in the absence of CD21/35 expression. Immunol 2004; 172:5833-5837.
5. Nilsson UR, Nilsson B: Simplified assays of hemolytic activity of the classical and alternative complement pathways. J Immunol Methods 1984; 72:49-59.
6. Whaley K: Measurement of complement. In Methods in Complement for the Clinical Immunologists. K Whaley (ed). Edinburgh, Churchill, Livingstone Ltd, 1985, pp 77-139.
7. Ish C, Ong GL, Desai N, Mattes MJ: The specificity of alternative complement pathway-mediated lysis of erythrocytes: a survey of complement and target cells from 25 species. Scand J Immunol 1993; 38:113-122.
8. Kim YU, Kinoshita T, Molina H, Hourcade D, Seya T, Wagner LM, Holers VM: Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein. J Exp Med 1995; 181:151-159.
9. Rushmere NK, Tomlinson S, Morgan BP: Expression of rat CD59: functional analysis confirms lack of species selectivity and reveals that glycosylation is not required for function. Immunology 1997; 90:640-646.
10. White RV, Kaufman KM, Letson CS, Platteborze PL, Sodetz JM: Characterization of rabbit complement component C8. Functional evidence for the species-selective recognition of C8 alpha by homologous restriction factor (CD59). J Immunol 1994; 152:2501-2508.
11. Yu J, Dong S, Rushmere NK, Morgan BP, Abagyan R, Tomlinson S: Mapping the regions of the complement inhibitor CD59 responsible for its species selectivity. Biochemistry 1997; 36:9423-9428.
12. Lindahl G, Sjöbring U, Johnsson E: Human complement regulators: a major target for pathogenic microorganisms. Curr Opin Immunol 2000; 12:44-51.
13. Kišová-Vargová L, Cerňanská D, Bhide M: Comparative study of binding of ovine complement factor H with different Borrelia genospecies. Folia Microbiol (Praha) 2012; 57:123-128.
14. van den Berg CW, Harrison RA, Morgan BP: The sheep analogue of human CD59: purification and characterization of its complement inhibitory activity. Immunology 1993; 78:349-357.
15. Wells B, Burgess ST, Nisbet AJ: Characterization of the ovine complement 4 binding protein-beta (C4BPB) chain as a serum biomarker for enhanced diagnosis of sheep scab. Mol Cell Probes 2013; 27:158-163.
16. Moreno-Indias I, Dodds AW, Argüello A, Castro N, Sim RB: The complement system of the goat: haemolytic assays and isolation of major proteins. BMC Vet Res 2012; 2012:91.
17. Castillo-Melendez M, Baburamani AA, Cabalag C, Yawno T, Witjaksono A, Miller SL, Walker DW: Experimental modelling of the consequences of brief late gestation asphyxia on newborn lamb behaviour and brain structure. PLoS ONE 2013; 8:e77377.
18. De Matteo R, Blasch N, Stokes V, Davis P, Harding R: Induced preterm birth in sheep: a suitable model for studying the developmental effects of moderately preterm birth. Reprod Sci 2010; 17:724-733.
19. Wolfson MR, Wu J, Hubert TL, Gregory TJ, Mazela J, Shaffer TH: Lucinactant attenuates pulmonary inflammatory response, preserves lung structure, and improves physiologic outcomes in a preterm lamb model of RDS. Pediatr Res 2012; 72:375-383.
20. Kemp MW, Saito M, Kallapur SG, Jobe AH, Keelan JA, Li S, Kramer B, Zhang L, Knox C, Yaegashi N, Newnham JP: Inflammation of the fetal ovine skin following in utero exposure to Ureaplasma parvum. Reprod Sci 2011; 18:1128-1137.
21. Dean JM, van de Looij Y, Sizonenko SV, Lodygensky GA, Lazeyras F, Bolouri H, Kjellmer I, Huppi PS, Hagberg H, Mallard C: Delayed cortical impairment following lipopolysaccharide exposure in preterm fetal sheep. Ann Neurol 2011; 70:846-856.
22. Zhang L, Saito M, Jobe A, Kallapur SG, Newnham JP, Cox T, Kramer B, Yang H, Kemp MW: Intra-amniotic administration of E coli lipopolysaccharides causes sustained inflammation of the fetal skin in sheep. Reprod Sci 2012; 19:1181-1189.
23. Beeton ML, Daha MR, El-Shanawany T, Jolles SR, Kotecha S, Spiller OB: Serum killing of Ureaplasma parvum shows serovar-determined susceptibility for normal individuals and common variable immuno-deficiency patients. Immunobiology 2012; 217:187-194.
24. Li S, Sehic E, Wang Y, Ungar AL, Blatteis CM: Relation between complement and the febrile response of guinea pigs to systemic endotoxin. Am J Physiol 1999; 277:R1635-R1645.
25. Sun S, Guo Y, Zhao G, Zhou X, Li J, Hu J, Yu H, Chen Y, Song H, Qiao F, Xu G, Yang F, Wu Y, Tomlinson S, Duan Z, Zhou Y: Complement and the alternative pathway play an important role in LPS/D-GalN-induced fulminant hepatic failure. PLoS ONE 2011; 6:e26838.
26. Lillegard KE, Johnson AC, Lojovich SJ, Bauer AJ, Marsh HC, Gilbert JS, Regal JF: Complement activation is critical for placental ischemia-induced hypertension in the rat. Mol Immunol 2013; 56:91-97.
27. Souza DG, Esser D, Bradford R, Vieira AT, Teixeira MM: APT070 (Mirococept), a membrane-localised complement inhibitor, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injury. Br J Pharmacol 2005; 145:1027-1034.
28. Wagner E, Platt JL, Howell DN, Marsh HC Jr, Frank MM: IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model. J Immunol 1999; 163:3549-3558.
29. Weiser MR, Pechet TT, Williams JP, Ma M, Frenette PS, Moore FD, Kobzik L, Hines RO, Wagner DD, Carroll MC, Hechtman HB: Experimental murine acid aspiration injury is mediated by neutrophils and the alternative complement pathway. J Appl Physiol (1985) 1997; 83:1090-1095.
30. Weisman HF, Bartow T, Leppo MK, Marsh HC Jr, Carson GR, Concino MF, Boyle MP, Roux KH, Weisfeldt ML, Fearon DT: Soluble human complement receptor type 1; in vivo inhibitor of complement suppressing post-ischemic mycocardial inflammation and necrosis. Science 1990; 249:146-151.
31. Gorsuch WB, Chrysanthou E, Schwaeble WJ, Stahl GL: The complement system in ischemia-reperfusion injuries. Immunobiology 2012; 217:1026-1033.
32. Ambati J, Atkinson JP, Gelfand BD: Immunology of age-related macular degeneration. Nat Rev Immunol 2013; 13:438-451.
33. McCaughan JA, O'Rourke DM, Courtney AE: The complement cascade in kidney disease: from sideline to center stage. Am J Kidney Dis 2013; 62:604-614.
34. Barilla-Labarca ML, Toder K, Furie R: Targeting the complement system in systemic lupus erythematosus and other diseases. Clin Immunol 2013; 148:313-321.
35. Crehan H, Holton P, Wray S, Pocock J, Guerreiro R, Hardy J: Complement receptor 1 (CR1) and Alzheimer's disease. Immunobiology 2012; 217:244-250.
36. Palmeira P, Quinello C, Silveira-Lessa AL, Zago CA, Carneiro-Sampaio M: IgG placental transfer in healthy and pathological pregnancies. Clin Dev Immunol 2012; 2012:13 Article ID 985646.
37. Morris IG, Barron AA: The protein composition of sheep foetal fluids. Vet Immunol Immunopathol 1980; 1:153-161.
38. Omwandho CA, Hall AL, Falconer J, Roberts TK: Elution and partial characterization of immunoglobulins bound to ovine placenta. Immunol Cell Biol 1997; 75:231-237.
39. Pentsuk N, van der Laan JW: An interspecies comparison of placental antibody transfer: new insights into developmental toxicity testing of monoclonal antibodies. Birth Defects Res B 2009; 86:328-344.